Breakthroughs in Biotechnology Seminar Series: Advances in CAR-T cell therapy: CTL019 and Beyond
- Starts: 4:00 pm on Thursday, November 9, 2017
Breakthroughs in Biotechnology Seminar Series Sponsored by the Biological Design Center Talk title: Advances in CAR-T cell therapy: CTL019 and Beyond Jennifer Brogdon, PhD Director, Exploratory Immuno-Oncology Novartis Institutes for Biomedical Research Reception to follow talk Dr. Brogdon will highlight how her group at Novartis developed CTL019 – the first FDA approved CAR-T cell therapy (KymriahTM) - through their collaboration with UPenn, some of the unique aspects of developing a novel cell and gene therapy, and the technologies and resources that NIBR brings to bear on such a collaboration. The Breakthroughs in Biotechnology Seminar Series, sponsored by the Biological Design Center, brings in industry scientists from across the biotechnology space to highlight their exciting research from developing new technologies, to therapeutics, medical devices and beyond.
- Kilachand Center for Integrated Life Science and Engineering Room 101